Compare ZLAB & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZLAB | ERO |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 3.2B |
| IPO Year | 2017 | 2021 |
| Metric | ZLAB | ERO |
|---|---|---|
| Price | $16.62 | $25.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $49.60 | $36.50 |
| AVG Volume (30 Days) | 793.9K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $9.75 | $51.94 |
| Revenue Next Year | $26.03 | $2.43 |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $12.79 |
| 52 Week High | $44.34 | $39.80 |
| Indicator | ZLAB | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 31.99 | 40.62 |
| Support Level | $15.96 | $25.68 |
| Resistance Level | $19.64 | $26.77 |
| Average True Range (ATR) | 0.62 | 1.51 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 8.85 | 2.52 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.